Let’s start with the good news. On Oct. 13 in Israel, more than 300,000 students started the academic year at universities and colleges around the country. In the past decade, the percentage of Israelis accepted into institutions of higher learning has increased from some 20% of the relevant age group to almost 50%. Since the mid-1990s, Israel has ranked third in the number of scientific citations (relative to country wealth) and third in the number of scientific publications per million residents. Since 2000, five Israeli scientists have been awarded Nobel prizes.
From the world’s most prestigious award, we now move to the bad news in the areas of science, research and higher learning in Israel. Two of the three laureates for the 2013 Nobel Prize in Chemistry, Arieh Warshel and Michael Levitt, emigrated from Israel and make their homes in the United States. Many in Israel regard them as “descenders,” the translation of a term coined in Hebrew to describe those who leave the country. In the outspoken words of retired general Uzi Dayan, they are “traitors.”
The retired general’s declaration on his Facebook page is not sophisticated: “Leaving (descending from) Israel will ever be considered in my eyes as a betrayal of the Zionist idea — the return of the Jewish people to his homeland. I also loathe those who move to Germany. To those who explain leaving because of the economic situation, I remind of the anti-Semite claim, according to which Jews find their home in the place where they feel comfortable. Zionism claims that Jews can be well only in a Jewish state. True, many things here are in need of fixing. But they are to be fixed here only. Anyone can choose where he lives, and I am entitled to give my opinion on that.”
Daniel Barenboim, Pinchas Zukerman, Daniel Kahneman, Haim Saban and thousands of other Israeli musicians, scientists and entrepreneurs who bestow honor on their state — are they all “traitors”?
AL-MONITOR All-Access gives you unlimited access to all our journalism, the full Daily Briefing, exclusive interviews, premium newsletters, and live events — for less than $2/week.